Dermatology Times, February 2020 (Vol. 41, No. 2)

Rosacea commonly underdiagnosed

February 12, 2020

It's thought that rosacea affects about 10% of the population, but this estimation may not be completely accurate as the condition is often underdiagnosed – especially in individuals with darker skin types.

Technology targets non-genital warts

February 12, 2020

Positive results from a study investigating non-thermal Nano-Pulse Stimulation as a treatment for cutaneous non-genital warts have led to a larger multicenter study that is looking to optimize treatment parameters and hopefully replicate the early evidence of its efficacy and safety.

Can sweat shed a light on disease severity in atopic dermatitis?

February 12, 2020

A wearable patch may soon be able to assess inflammatory biomarkers found in the sweat and interstitial fluid in individuals with atopic dermatitis to ultimately provide real-time information about their skin health.

An investigational drug for keloids

February 07, 2020

The atopic dermatitis treatment dupilumab could offer a therapeutic option for keloids, according to a case report published in the Journal of European Academy of Dermatology and Venereology.

Study supports evidence on indoor tanning risk

February 07, 2020

A cohort study reveals the dose-response association between cumulative number of sessions and cutaneous squamous cell carcinoma (cSCC) risk in women was the same regardless of duration of use or age at indoor tanning initiation. 

Tape strips may replace biopsies in pediatric atopic dermatitis

December 13, 2019

Biopsies are the gold standard approach for obtaining skin samples to test for biomarkers in atopic dermatitis, but tape strips may offer a far less invasive alternative for young children with the disease, research suggests.

Aggressive, early treatment may prevent acne scars

December 10, 2019

Treating all acne early with a topical retinoid and an antibiotic can help patients avoid scarring and its psychosocial consequences, experts say. The aggressive approach also may help stave off medicolegal concerns, they add.

IL-17 potential therapeutic target for pustular psoriasis

November 19, 2019

Researchers performed a systematic review of available reports on the therapeutic benefit of interleukin (IL)-17/T-helper 17 (Th17) axis inhibitors in patients with generalized pustular psoriasis (GPP). Read what they discovered in this article.